Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
Add more filters










Publication year range
4.
US News World Rep ; 117(13): 44-5, 47, 1994 Oct 03.
Article in English | MEDLINE | ID: mdl-10138333
6.
US News World Rep ; 117(8): 43, 1994 Aug 22.
Article in English | MEDLINE | ID: mdl-10137270
7.
US News World Rep ; 117(1): 30, 1994 Jul 04.
Article in English | MEDLINE | ID: mdl-10135080
10.
US News World Rep ; 116(9): 48-50, 1994 Mar 07.
Article in English | MEDLINE | ID: mdl-10161047
14.
19.
Onkologie ; 7(6): 348-53, 1984 Dec.
Article in German | MEDLINE | ID: mdl-6396562

ABSTRACT

A three drug combination consisting of dacarbazine, vindesine and CDDP (DVP) was used for isolated extremity perfusion in 26 patients with stage I, II and III melanomas of the limbs. Dosages of 100 mg/l dacarbazine, 0.4 mg/l vindesine and 20 mg Cis-Platinum/l extremity volume have been tolerated without major side effects. All perfusions of bulky tumors or metastases resulted in more than 50% tumor-size reduction (8 patients stage III A, 6 patients stage III AB). In five stage III patients relapse occurred 2, 3, 5, 6 months after isolated DVP perfusion.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Melanoma/drug therapy , Skin Neoplasms/drug therapy , Chemotherapy, Cancer, Regional Perfusion/adverse effects , Chemotherapy, Cancer, Regional Perfusion/methods , Cisplatin/administration & dosage , Dacarbazine/administration & dosage , Humans , Leg , Lymphatic Metastasis , Melanoma/mortality , Neoplasm Staging , Skin Neoplasms/mortality , Vinblastine/administration & dosage , Vinblastine/analogs & derivatives , Vindesine
SELECTION OF CITATIONS
SEARCH DETAIL
...